ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

154
Analysis
Health CareSouth Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
bullishLG Chem Ltd
04 Sep 2020 12:20

Korea-New Deal Index: Constituents, Weights, & Market Reaction

The Korean government unveiled the specifics of the Korean version of the New Deal initiative.

Logo
422 Views
Share
10 Aug 2020 05:33

SK Biopharmaceuticals - KOSPI200 Inclusion Confirmed, Large Impact Expected

Late Friday evening, the KRX confirmed something that was widely expected. SK Biopharmaceuticals (326030 KS) meets the Fast Entry criteria for...

Logo
520 Views
Share
10 Aug 2020 01:07

Fast Entry of SK Biopharmaceuticals to KRX Indices, Incl. KOSPI 200

The KRX officially announced the fast entry of SK Biopharm to the following KRX indices in the form of Fast Entry. KOSPI 200 Fast-Entry If an IPO...

Logo
479 Views
Share
03 Aug 2020 14:57

Impact of SK Biopharm Lock-Up Expirations

In this insight, we provide an analysis of the upcoming lock-up expirations of SK Biopharmaceuticals (326030 KS), which are likely to put continued...

Logo
412 Views
Share
12 Jul 2020 07:57

Last Week In Event SPACE: FamilyMart, Sina, Line Corp, Metlifecare, Accordia Golf, Jingjeng, O-Net

Last Week in Event SPACE ... Interestingly, the impact of FamilyMart Co Ltd (8028 JP)'s shareholder dynamic on price may not be what "smart"...

Logo
602 Views
Share
x